MARY HOLTHAUS PA
Prescription History 1285296913
Physician Assistant - Medical in Annapolis, MD

NPI Status: Active since July 02, 2019

Contact Information

122 DEFENSE HWY STE 210
ANNAPOLIS, MD
ZIP 21401
Phone: (410) 266-9694

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MARY HOLTHAUS PA, an active Medical specialist practicing in Annapolis, MD. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 673 documented patient claims. Among these therapy options, the most frequently utilized medication is Memantine Hcl, which accounts for 149 claims alone.


Aimovig Autoinjector

Generic Formulation: Erenumab-AooeSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 17
30-Day Fills 26.6
Days Supply 798
MD State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills31.7
Peer Average Days Supply940
Conservative Utilization

This provider writes prescriptions for this formulation 26.1% less frequently than the standard regional baseline metric for practitioners inside MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $20,155.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,185.60

State Avg Cost Per Claim

$1,002.90

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to help prevent migraine. This medication may work by changing the amounts of certain natural substances in the brain. Erenumab belongs to a class of drugs known as monoclonal antibodies. Preventing frequent migraine attacks can help improve your ability to concentrate and do your usual tasks.

Donepezil Hcl

Generic Formulation: Donepezil HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 139
30-Day Fills 392.0
Days Supply 11,728
MD State Average Benchmarks
Peer Average Claims47.0
Peer Average 30-Day Fills81.5
Peer Average Days Supply2,365
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 195.7% higher than the standard regional baseline profile for MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,387.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.18

State Avg Cost Per Claim

$18.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Donepezil is used to treat confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to function. This medication is an enzyme blocker that works by restoring the balance of natural substances (neurotransmitters) in the brain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 12
30-Day Fills 26.0
Days Supply 780
MD State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills70.6
Peer Average Days Supply2,086
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 67.6% less volume than the regional standard for practitioners inside MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $492.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$41.01

State Avg Cost Per Claim

$53.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Eletriptan Hbr

Generic Formulation: Eletriptan HydrobromideSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 372
MD State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills16.1
Peer Average Days Supply319
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $558.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$39.87

State Avg Cost Per Claim

$157.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Eletriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Eletriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Eletriptan does not prevent future migraines or lessen how often you get migraine attacks.

Emgality Pen

Generic Formulation: Galcanezumab-GnlmSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 37
30-Day Fills 38.8
Days Supply 1,102
MD State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills30.7
Peer Average Days Supply901
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 42.3% more claims than the standard regional baseline profile for MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,957.86 across this reporting matrix range.

Provider Avg Cost Per Claim

$755.62

State Avg Cost Per Claim

$862.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to help prevent migraine. It is also used to treat a certain type of headache (episodic cluster headache). Galcanezumab belongs to a class of drugs known as monoclonal antibodies. This medication may work by changing the amounts of certain natural substances in the brain. Using this medication can help improve your ability to concentrate and do your usual tasks.

Gabapentin

Generic Formulation: GabapentinSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 93
30-Day Fills 194.0
Days Supply 5,704
MD State Average Benchmarks
Peer Average Claims66.0
Peer Average 30-Day Fills104.6
Peer Average Days Supply3,047
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 40.9% more claims than the standard regional baseline profile for MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,202.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.93

State Avg Cost Per Claim

$21.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Memantine Hcl

Generic Formulation: Memantine HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 149
30-Day Fills 350.6
Days Supply 10,425
MD State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills69.4
Peer Average Days Supply1,973
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 238.6% higher than the standard regional baseline profile for MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,311.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$49.07

State Avg Cost Per Claim

$60.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Memantine is used to treat moderate to severe confusion (dementia) related to Alzheimer's disease. It does not cure Alzheimer's disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by blocking the action of a certain natural substance in the brain (glutamate) that is believed to be linked to symptoms of Alzheimer's disease.

Propranolol Hcl

Generic Formulation: Propranolol HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 12
30-Day Fills 28.0
Days Supply 840
MD State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills35.7
Peer Average Days Supply1,044
Conservative Utilization

This provider writes prescriptions for this formulation 42.9% less frequently than the standard regional baseline metric for practitioners inside MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $102.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.51

State Avg Cost Per Claim

$24.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Propranolol Hcl Er

Generic Formulation: Propranolol HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 16
30-Day Fills 34.0
Days Supply 1,020
MD State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills38.5
Peer Average Days Supply1,144
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,125.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$70.36

State Avg Cost Per Claim

$84.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This formulation of propranolol is used for infants and children to treat a certain benign tumor (proliferating infantile hemangioma). It helps to shrink the tumor. Propranolol belongs to a class of drugs known as beta blockers.

Rivastigmine

Generic Formulation: RivastigmineSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 25
30-Day Fills 61.0
Days Supply 1,830
MD State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills30.1
Peer Average Days Supply801
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,115.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$444.62

State Avg Cost Per Claim

$88.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

Therapeutic Applications

Rivastigmine is used to treat confusion (dementia) related to Alzheimer's disease and to Parkinson's disease. Rivastigmine does not cure either of these diseases, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of natural substances (neurotransmitters) in the brain.

Rizatriptan

Generic Formulation: Rizatriptan BenzoateSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.0
Days Supply 523
MD State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills20.8
Peer Average Days Supply522
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $372.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.68

State Avg Cost Per Claim

$32.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Rizatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Rizatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Rizatriptan does not prevent future migraines or lessen how often you get migraine attacks.

Sertraline Hcl

Generic Formulation: Sertraline HclSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 44
30-Day Fills 110.0
Days Supply 3,300
MD State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills93.1
Peer Average Days Supply2,726
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $505.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.49

State Avg Cost Per Claim

$12.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Sertraline is used to treat depression, panic attacks, obsessive compulsive disorder, post-traumatic stress disorder, social anxiety disorder (social phobia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder). This medication may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Sertraline is known as a selective serotonin reuptake inhibitor (SSRI). It works by helping to restore the balance of a certain natural substance (serotonin) in the brain.

Sumatriptan Succinate

Generic Formulation: Sumatriptan SuccinateSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 27
30-Day Fills 27.0
Days Supply 695
MD State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills23.3
Peer Average Days Supply601
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 35.0% more claims than the standard regional baseline profile for MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $376.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.95

State Avg Cost Per Claim

$41.76

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.

Therapeutic Applications

Sumatriptan is used to treat migraines and cluster headaches. It helps to relieve pain and other symptoms of migraines/headaches including sensitivity to light or sound, nausea, and vomiting. Prompt treatment allows you to get back to your normal routine and may decrease your need for other pain medications. It does not prevent future migraines/headaches or reduce how often you may get a headache. Sumatriptan belongs to a group of drugs called triptans. It affects a certain natural chemical (serotonin) that constricts blood vessels in the brain. It may also block other pain pathways in the brain.

Topiramate

Generic Formulation: TopiramateSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 16
30-Day Fills 26.0
Days Supply 751
MD State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills44.8
Peer Average Days Supply1,306
Conservative Utilization

This provider writes prescriptions for this formulation 40.7% less frequently than the standard regional baseline metric for practitioners inside MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $224.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.02

State Avg Cost Per Claim

$21.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Ubrelvy

Generic Formulation: UbrogepantSpecialty: Physician Assistant
Provider Metrics Summary
Total Claims 54
30-Day Fills 56.0
Days Supply 1,387
MD State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills20.9
Peer Average Days Supply488
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 170.0% higher than the standard regional baseline profile for MD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $68,991.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,277.63

State Avg Cost Per Claim

$1,233.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat migraine. Ubrogepant may work by changing the amount of a certain natural substance in the brain. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. This medication is not used to prevent future migraines or lessen how often you get migraines.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MARY HOLTHAUS PA provides transparency into local medical care patterns within Annapolis, MD.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Medical** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.